Johnson & Johnson’s big breakup: Can Kenvue fly solo?
Johnson & Johnson (J&J), one of the world’s most recognizable healthcare conglomerates, has officially spun off its consumer health division into a standalone entity: Kenvue. This move marks a major transformation in J&J's corporate strategy, shifting its focus to pharmaceuticals and medical technology while letting Kenvue take the reins of its consumer brands.
But the big question is: Can Kenvue thrive on its own, or will it struggle without the J&J powerhouse behind it? Let’s dive into the details of this corporate breakup, what it means for both companies, and whether Kenvue has the wings to soar solo.
Keep reading with a 7-day free trial
Subscribe to Winvesta Crisps to keep reading this post and get 7 days of free access to the full post archives.